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Introduction
In the late 1990s, a convergence of findings coming princi-
pally from molecular studies of cholesterol homeostasis and of 
Alzheimer’s disease (AD) gave rise to a new concept in bio-
chemistry: regulated intramembrane proteolysis (RIP; Brown 
et al., 2000). Ensuing research led to the recognition of RIP 
as a universal signaling mechanism conserved from bacteria to 
humans. RIP involves the cleavage of diverse transmembrane 
proteins within the hydrophobic bilayer, resulting in the release 
of water-soluble fragments, many of which are essential for cel-
lular signaling. Such proteolytic events are now known to be 
catalyzed by one of several intramembrane proteases that in-
clude Rhomboid, site-2 protease (S2P), γ-secretase, and signal 
peptide peptidase. RIP often begins with an initial proteolytic 
cleavage that sheds the soluble ectodomain of the transmem-
brane substrate, allowing subsequent cleavage by the respective 
intramembrane proteases.
Perhaps the most studied of the intramembrane proteases 
is the γ-secretase complex, a highly conserved signaling hub 
that processes a large and growing list of single transmembrane 
proteins that function in diverse biological pathways rang-
ing from development to neurodegeneration (Jurisch-Yaksi et 
al., 2013). Cleavage of one such substrate, Notch, is required 
for cell fate determinations in metazoans (De Strooper et al., 
1999; Greenwald, 2012), and the processing of another sub-
strate, β-amyloid precursor protein (APP), generates the neu-
rotoxic amyloid β-peptide (Aβ) centrally implicated in AD 
(Hardy and Selkoe, 2002). Aβ is generated normally when APP 
undergoes shedding of its N-terminal ectodomain (amyloid 
precursor protein soluble–β [APPs-β]) by β-secretase, leaving a C- 
terminal stub (C99) that is then cleaved by γ-secretase within 
its transmembrane domain (TMD) to release Aβ and the APP 
intracellular domain (AICD; Fig. 1 A). Because it generates Aβ, 
γ-secretase is a target for the development of inhibitors to treat 
AD. Several γ-secretase inhibitors have reached human test-
ing. However, these trials have met with complications because 
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γ-secretase normally processes many substrates besides APP, as 
shown by the failure of semagacestat (Doody et al., 2013).
Although much attention has focused on the APP am-
yloidogenic pathway just described, APPs (and many other 
γ-secretase substrates) are predominantly processed by an 
alternate pathway involving ectodomain shedding by an 
α-secretase, followed by constitutive γ-secretase cleavage. 
In the example of APP, α-secretase cleaves within the Aβ re-
gion, liberating a slightly longer ectodomain (amyloid pre-
cursor protein soluble–alpha [APPs-α]) and leaving a shorter 
transmembrane stub (C83) that is then cleaved by γ-secretase 
to generate the small p3 peptide and AICD (Fig.  1  A). 
α-Secretase cleavage is usually performed by a member of the 
ADAM (a disintegrin and metalloproteinase) family, which 
processes many type I transmembrane substrates involved 
in myriad signaling pathways (Weber and Saftig, 2012). 
ADAM10 (A10) is the physiologically relevant α-secretase 
for ectodomain shedding of APP and other substrates in pri-
mary neurons and many cell lines (Kuhn et al., 2010). Reg-
ulated shedding by α-secretase via phorbol ester stimulation 
is likely catalyzed by TNF-converting enzyme (TACE, or 
ADAM17; Buxbaum et al., 1998).
Despite the wealth of information about the α-, β-, and 
γ-secretases individually, almost nothing is known about whether 
these proteases interact and whether there is a mechanism by 
which they regulate each other’s activities. There are two general 
possibilities as to whether α- and γ-secretases coordinate their 
sequential activities. One model is the current assumption that 
the α- and γ-secretase cleavages are separated spatially and tem-
porally in distinct membrane loci (Fig. 1 B). Such a mechanism 
would seem inefficient, as the hydrophobic C-terminal trans-
membrane fragments (CTFs) that are created by α- or β-secretase 
would have to traffic within the lipid bilayer to distinct mem-
brane loci where γ-secretase resides for further processing. We 
hypothesized instead that the α- and γ-secretases are physically 
linked to facilitate sequential processing of substrates (Fig. 1 C). 
We based this new hypothesis in large part on our identification 
of Aph-1 as a docking site within the γ-complex for both full-
length and ectodomain-shed substrates (Chen et al., 2010). It 
was unclear why full-length proteins, which are not the direct 
targets of γ-secretase, would interact with the γ-complex, un-
less only full-length substrates that are about to be processed 
by α-secretase enter a combined complex for efficient sequen-
tial processing. This hypothesis suggests that the sheddase and 
Figure 1. Models of APP processing by the vari-
ous secretases. (A) Processing of APP by α-, β-, and 
γ-secretases. (B) Current model of γ-secretase sub-
strate processing in which the ectodomain shedding 
and the intramembrane cleavages are assumed 
to be separated spatially and temporally. (C) Pro-
posed new model of γ-secretase processing based 
on all data herein in which the principal sheddase 
(α-/β-secretase) exists in an HMW complex with 
γ-secretase that accepts full-length substrates for 
rapid sequential processing.
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γ-secretase may not be separated spatially but, rather, occur in 
the same physical complex. There is sparse emerging evidence 
that substrate processing by the different secretases may be 
more interconnected than thought heretofore. For example, an 
APP-based peptidomimetic inhibitor of γ-secretase (based on 
the transmembrane domain sequence just downstream of Aβ) 
inhibited γ processing of APP but also altered APP ectodomain 
shedding (Esselens et al., 2012). In addition, there is evidence 
that α-secretase may serve not only to remove the ectodomain 
of substrates, but also to “hand off” substrates to γ-secretase 
for processing (Hemming et al., 2008). When the C-terminal 
region of a nonsubstrate (integrin-β1) was fused to the large 
ectodomain of a γ substrate (vasorin), this chimeric substrate 
could be shed in cells by α-secretase, and the resultant α-CTF 
was then cleaved by γ-secretase. However, if only the α-CTF of 
this chimeric substrate was directly expressed, it could not be 
cleaved by γ-secretase. This finding raised the possibility that 
α processing may be required for the passing of a substrate on 
to γ-secretase and that having a permissive γ sequence is not 
sufficient to yield γ cleavage in cells.
Here, we examine in detail the concept that substrate pro-
cessing by α- and γ-secretase is interrelated both physically and 
functionally. We identify a novel interaction of γ-secretase with 
A10. We propose a new model in which the α- and γ-secretases 
reside in a complex capable of accepting full-length substrates 
for efficient, sequential processing. This interaction, which we 
show, also applies to β-secretase (β-site APP-cleaving enzyme 1 
[BACE1]) and may be extendable to other intramembrane pro-
teases that require a prior cleavage event.
Results
γ-Secretase interacts with the 
α-secretases A10 and TACE at both 
overexpressed and endogenous levels, 
including on the plasma membrane
Although full-length substrates are not the immediate proteolytic 
targets of γ-secretase, we and others have obtained evidence that 
they can interact with the γ-complex (Xia et al., 1997b; Ray et 
al., 1999; Chen et al., 2010). On this basis, we hypothesized that 
the α- and γ-secretases may function together in a larger multi-
meric complex for efficient substrate processing. To determine 
whether α-secretase associates with γ-secretase, we initially 
examined our γ-30 cell line: CHO cells that stably overexpress 
human APP, three of the four human γ components (Presenilin1 
[PS1], Aph-1, and Pen-2, but not Nicastrin [NCT]), and trans-
ferrin receptor (TFR; Kimberly et al., 2003). These cells express 
only endogenous A10 and TACE, the predominant α-secretases 
for APP. Each ADAM is synthesized as an inactive proprotein 
(immature) that undergoes a Furin-like cleavage leading to mat-
uration. Mature TACE (but not mature A10) is highly unstable 
after cell lysis (Schlöndorff et al., 2000) but can be detected well 
when cells are lysed in the presence of a metalloprotease inhib-
itor like 1,10-phenanthroline (Fig. 2 A, compare lanes 1 and 2). 
By enriching for γ-secretase via Aph-1 immunoprecipitation 
(IP) of lysates made in 1% 3-([3-cholamidopropyl]dimethylam-
monio)-2-hydroxy-1-propanesulfonate (CHA PSO; one of the 
few detergents that leaves the γ-complex intact), we detected the 
coimmunoprecipitation (coIP) of A10 and TACE (Fig. 2 A, lanes 
3 and 4). Next, we performed coIPs in the reverse direction: A10 
immunoprecipitates were probed for the coIP of PS1 CTF, and as 
a control, lysates were immunoprecipitated for the known non–γ 
substrate natriuretic peptide receptor A (NPR A; Hemming et 
al., 2008). We observed coIP of γ-secretase (PS1 CTF) only in 
the A10 immunoprecipitates (Fig. 2 B). To rule out nonspecific 
protein interaction after lysis, lysates of cells that contained no 
γ-secretase (α+, γ−; Fig. 2 C, lane 1) and lysates of cells that 
contained no A10 (α−, γ+; Fig. 2 C, lane 2) were mixed (Mix 
1; Fig. 2 C, lane 5) and immunoprecipitated for γ-secretase (see 
Sample preparation and IP in Materials and methods for details). 
We saw no coIP of A10 (Fig.  2 C, lane 7), even though there 
were significant levels of A10 in the starting mix (Fig. 2 C, lanes 
1 and 5). As a positive control for this experiment, lysates that 
contained neither A10 nor γ-secretase (α−, γ−; Fig. 2 C, lane 3) 
or lysates that contained both proteases (α+, γ+; Fig. 2 C, lane 
4) were mixed and immunoprecipitated for γ-secretase. We ob-
served a robust coIP of A10 with the γ components (Fig. 2 C, lane 
8). Together, these control experiments indicate that the associa-
tion between A10 and γ-secretase is not a result of nonspecific 
postlysis interaction, but occurs within cells.
Next, we sought to establish that the secretases can inter-
act at the plasma membrane where they are known to be pro-
teolytically active (Gutwein et al., 2003; Chyung et al., 2005) 
and involved in many forms of cell signaling. Live γ-30 cells 
were treated with a nonpenetrant biotinylation reagent (or not) 
at 4°C to label surface proteins. Surface-biotinylated and con-
trol cell lysates were enriched for intact γ-secretase by IP of 
Aph-1, an early member in γ-complex assembly (LaVoie et 
al., 2003). The resultant immunoprecipitates were subjected to 
streptavidin pull-down to enrich for cell surface interactors of 
γ-secretase. Aph-1 coimmunoprecipitated both immature and 
mature endogenous A10; however, mostly mature A10 was 
detected in the subsequent streptavidin pull-down, suggesting 
that mature A10 interacts with γ-secretase at the CHO cell sur-
face (Fig. 2 D). As a control for proper cell surface labeling, no 
immature NCT (ER localized) was detected in the streptavidin 
pull-down (Fig.  2  D, lane 6). A similar coimmunoprecipitate 
was observed for TACE: only the mature form was recovered 
with γ-secretase at the cell surface (Fig. S1 A). Immunoprecip-
itating γ-secretase via Pen-2 (the last component of γ-secretase 
to join the complex) enriched predominantly for mature γ- 
complexes (as opposed to immature), and at the cell surface, the 
biotinylated γ-complex was associated with biotinylated mature 
A10 (Fig. S1 B). Thus, portions of mature α- and γ-secretases 
interact at the plasma membrane, a location where each has 
been shown to be active.
We sought to validate the interaction of γ-secretase with 
A10 and TACE under solely endogenous expression. Using 7W 
CHO cells, the parental line of the γ-30 cells that expresses 
only endogenous γ components, we detected coIP of active, 
mature γ-secretase (i.e., PS1 N-terminal transmembrane frag-
ment [NTF]/CTF) when 7W lysates made in the presence of 
phenanthroline were immunoprecipitated for endogenous 
TACE using two different antibodies, whereas protein A aga-
rose (PAA) beads alone brought down no γ-secretase compo-
nents (Fig.  3 A). However, in the absence of phenanthroline, 
very little mature TACE was present and immunoprecipitated, 
and the levels of PS1 CTF that coimmunoprecipitated were 
correspondingly very low (Fig.  3  A, lanes 5 and 7). This se-
lectivity of endogenous PS1 binding to endogenous mature but 
not immature TACE (although the two forms are closely simi-
lar transmembrane polypeptides) supports the specificity of our 
coIP. Thus, in 7W cells, endogenous mature TACE can interact 
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in part with endogenous γ-secretase. Next, we asked whether 
this interaction was conserved in the human neuroblastoma cell 
line, M17D. These cells have high levels of both mature and 
immature A10 but no detectable mature TACE (only immature). 
When M17D cells were lysed in the presence of phenanthroline 
and immunoprecipitated for A10 or TACE, we observed clear 
coIP of PS1 NTF and CTF with A10 but virtually no interaction 
with TACE (Fig. 3 B), suggesting that in these neural cells, an 
endogenous A10–γ-secretase complex is more abundant than a 
TACE–γ-secretase complex, presumably as a result of the low 
level of mature TACE endogenously (Fig. 3 B).
To confirm the interaction in a more physiological system, 
we prepared microsomes from wild-type (WT) adult mouse 
brain and solubilized them in 1% CHA PSO, immunoprecipi-
tated for A10 with two distinct antibodies, and blotted for coIP 
of PS1 CTF (Fig. 3 C). We observed coIP of γ-secretase with 
mature A10 in this tissue, further supporting that the interaction 
is physiological. Next, we asked whether other ADAM mem-
bers interact with γ-secretase in brain. Mouse brain microsomes 
were immunoprecipitated for ADAM9, TACE, or A10 and 
blotted for PS1 CTF. In brain, as in M17D cells, we observed 
mostly immature TACE and detected no coIP of γ-secretase 
with the TACE antibody (Fig. 3, D and E). Likewise, we did 
not observe any coIP of PS1 CTF by ADAM9 IP (Fig. 3 D). 
These results provide important specificity controls for our co-
immunoprecipitates: only immunoprecipitating for A10 among 
these three type I transmembrane proteins consistently brought 
down endogenous PS1 CTF from normal brain (Fig. 3, D and 
Figure 2. The α-secretases A10 and TACE interact with γ-secretase at overexpressed levels and at the plasma membrane. (A) CHA PSO-solubilized lysates 
of γ-30 CHO cells were immunoprecipitated for Aph-1 or PAA as a control in the absence or presence of the metalloprotease inhibitor 1,10-phenanthroline. 
Immunoprecipitates were blotted to probe for coIP of A10 or TACE, APP, and for the γ components NCT and Pen-2. (B) γ-30 lysates were immunoprecipi-
tated for either A10 or NPR A as a control. Resulting immunoprecipitates were probed for the coIP of PS1 CTF. (C) Lysates from cells that express A10 only, 
human γ-secretase only, neither, or both (lanes 1, 2, 3, and 4, respectively) were specifically pooled to form mix 1 (A10 only + γ-secretase only) or mix 
2 (neither + both) and then immunoprecipitated for γ-secretase with an M2 resin targeting the Flag tag on Pen-2. Immunoprecipitates were probed for the 
coIP of A10 and the γ components PS1 NTF and Pen-2. (D) γ-30 cells were treated with a nonpermeable biotinylation reagent at 4°C to label cell surface 
proteins. Lysates were immunoprecipitated for Aph-1, and the resultant immunoprecipitates were eluted and pulled down with streptavidin to enrich for cell 
surface interactors of γ-secretase, followed by blotting for α- and γ-secretases as in A. im, immature; m, mature.
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Figure 3. The association between A10 and γ-secretase is observed at endogenous expression levels in cells and WT mouse brain. (A) 7W cells were 
lysed in 1% CHA PSO in the absence or presence of 1,10-phenanthroline, immunoprecipitated for TACE or just with PAA, and then probed for coIP of PS1 
CTF. (B) M17D cells were lysed in CHA PSO with 1,10-phenanthroline. Lysates were immunoprecipitated for TACE or A10 and probed for coIP of PS1 CTF. 
(C) Microsomes prepared from WT mouse brains were immunoprecipitated for A10 with two different antibodies (19026 and 422751) and blotted for 
the coIP of PS1 CTF. (D and E) Mouse brain microsomes were immunoprecipitated for TACE, A10, or ADAM9 (A9) and controls of PAA only or TFR and 
probed for coIP of PS1 CTF, TFR, TACE, and A10. The asterisks indicate nonspecific bands. (F) Mouse brain microsomes were immunoprecipitated for PS1 
CTF and blotted for coIP of A10, PS1, and APH-1. im, immature; m, mature.
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E). As a further control for specificity, IP of TFR, a type II pro-
tein that does not interact with γ-secretase, brought down very 
little or no PS1 CTF (Fig.  3, D and E). These multiple con-
trols indicate that the interaction between A10 and γ-secretase 
is not a result of nonspecific interactions between membrane 
proteins. Next, we immunoprecipitated for PS1 in the mouse 
brain microsomes and blotted for A10. We detected interaction 
with A10 in this reverse direction; importantly, we again ob-
served principally mature A10 interacting with the components 
of γ-secretase (Fig. 3 F), supporting the conclusion that under 
entirely endogenous conditions, mature γ-secretase can associ-
ate with mature α-secretase.
Mature A10 and mature γ-secretase 
coexist in a high molecular weight 
(HMW) complex
The γ-secretase complex has been variably sized to be ∼250 
to >2,000 kD, depending on the techniques used (Yu et al., 
1998; Edbauer et al., 2002; Evin et al., 2005; Osenkowski et al., 
2009). To determine whether A10 exists in an HMW complex 
that also contains γ-secretase endogenously, we fractionated 
microsomes isolated from WT mouse brains on a Superose 6 
gel-filtration column. Mature A10 was present in HMW com-
plexes (>2 MD) that cofractionated well with mature γ-com-
plexes (Fig.  4  A). Importantly, previous use of a Superose 6 
column also showed that γ-secretase fractionated in an HMW 
complex of ∼2 MD (Li et al., 2000). Immature A10 predomi-
nantly eluted in much smaller complexes (<90 kD) that did not 
fractionate well with mature γ-secretase (Fig. 4 A). In another 
size-exclusion chromatography (SEC) run, we pooled fractions 
containing HMW proteins (∼2 MD; fractions 5–9) or low mo-
lecular weight (LMW) proteins (<90 kD; fractions 20–24) and 
immunoprecipitated each pool for A10. Only the HMW frac-
tions showed the coIP of mature γ-complexes (i.e., PS1 CTF 
and mature NCT) with mature A10 (Fig. 4 B, lane 4). A10 IP 
of the LMW fractions from the same SEC run brought down 
neither PS1 CTF nor mature NCT (Fig. 4 B, lane 5). These gel 
filtration experiments under native conditions demonstrate that 
a portion of mature A10 exists in an HMW complex with ma-
ture γ-secretase in normal brain.
Next, we performed blue native PAGE (BN-PAGE) on S20 
cells lysed in n-dodecyl β-d-maltoside (DDM) detergent. When 
we probed for γ-secretase components, we observed that they 
comigrated at ∼440 kD (Fig. 4 C), which is consistent with a 
previous study (Edbauer et al., 2002). When we probed for A10, 
we observed bands at 440 kD and 240 kD, and both these bands 
were shown to be specific to A10 using siRNA (Fig. 4 D). The 
440-kD A10 band comigrated with the HMW γ-secretase com-
plex. We also observed similar data in 7W cells (endogenous 
γ-secretase; unpublished data). Together, these data suggest that 
A10 and γ-secretase comigrate in an HMW complex by two 
independent nondenaturing methods, SEC and BN-PAGE.
The α–γ-secretase complex is 
proteolytically active
To confirm that the α–γ-secretase complexes we observed were 
proteolytically active, we performed typical in vitro γ-secretase 
activity assays on α-secretase immunoprecipitates. We used a 
recombinant APP-based γ substrate (C100-Flag) and quantified 
the generation of AICD and Aβ by Western blotting (WB). A10 
immunoprecipitates of S20 lysates, which coimmunoprecipi-
tated mature γ-secretase (e.g., PS1 NTF) as before, mediated 
the processing of the C100 substrate to generate Aβ and AICD, 
confirming γ activity in the A10 pull-down (Fig. 5 A, lanes 5 
and 6; quantification on the right). Aβ-specific ELI SAs con-
firmed the production of Aβ seen on the Western blot (not de-
picted). As a simultaneous positive control, a γ activity assay 
that was performed on a direct IP of PS1 NTF produced even 
more abundant Aβ and AICD, as expected (Fig. 5 A, lanes 3 
and 4). In the A10 IP, the C100 substrate underwent cleavage 
by A10 to a C83 fragment (Fig. 5 A, lanes 5 and 6); production 
of the latter was specifically inhibited by a known α-secretase 
inhibitor (TAPI-1; lanes 9 and 10). (That A10 can cleave C99 
to C83 is documented [Kuhn et al., 2010].) The C83 fragment 
then underwent processing by γ-secretase, as a γ inhibitor in-
creased its levels (Fig. 5 A, lanes 7 and 8), suggesting that se-
quential α–γ processing of the C100 substrate had occurred. 
However, we did not observe any processing of C99 to C83 in 
our PS1 IP (Fig. 5 A, lanes 3 and 4), likely because of the high 
levels of γ-secretase in those samples which may outcompete 
A10 for the C99 substrate; furthermore, the activity assay is 
optimized for γ-, not α-secretase activity, and the levels of α 
processing of C99 after a high enrichment of A10 (Fig. 5 A, 
lanes 5–8) were very low.
Next, we performed the reverse experiment: α-secretase 
activity assays were performed on γ-secretase IPs from the S20 
cells. Here, we used as a substrate an internally quenched fluo-
rogenic peptide designed for α-secretase–type metalloproteases 
that is unquenched upon cleavage. We immunoprecipitated for 
Flag–Pen-2 or Aph-1–HA (with M2 and 3F10 resins, respec-
tively), and as negative controls, we immunoprecipitated for 
TFR (an irrelevant membrane protein also overexpressed in the 
S20 cells) or else with M2 resin preabsorbed with Flag pep-
tide (Fig. 5 B). IP of Aph-1 (an early component in γ-secretase 
assembly) coimmunoprecipitated both mature and immature 
γ-complexes. However, IP of Pen-2 (the final component in γ 
assembly) coimmunoprecipitated mature γ-complexes (i.e., 
virtually all of the coimmunoprecipitated NCT was fully gly-
cosylated; compare Aph-1 and Pen-2 lanes in Fig.  5  B). In 
agreement, Aph-1 pulled down predominantly immature A10, 
whereas Pen-2 coimmunoprecipitated almost exclusively ma-
ture A10 (Fig.  5  B). As hypothesized, both these γ immuno-
precipitates yielded specific α-secretase activity (inhibitable by 
TAPI-1), whereas the negative controls (TFR IP or preabsorbed 
M2 IP) did not (quantified in Fig. 5 B, right). Together, these 
bidirectional coIPs indicate that the α–γ-secretase complex is 
proteolytically active, with each enzyme in the coprecipitated 
complex able to process substrate appropriately.
A10 partially colocalizes with γ-secretase 
by superresolution structured illumination 
microscopy (SIM) and fluorescence 
lifetime imaging
To support our biochemical findings, we first performed con-
focal immunofluorescence microscopy on 7W cells that ex-
press only endogenous α- and γ-secretases. Confocal imaging 
showed punctate staining for A10 and PS1 throughout the cell 
(Fig. 6 A), with the strongest colocalization near the cell pe-
riphery. To quantify the degree of colocalization between A10 
and γ-secretase, we performed an unbiased, automated analy-
sis to calculate the Pearson correlation coefficient (PCC; Fig. 
S2 C; Manders et al., 1992) and observed a PCC of 0.67 ± 
0.08, whereas overlap between PS1 and a nonspecific single- 
transmembrane protein, TFR (Fig. S2 A), was significantly less 
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at 0.35 ± 0.15, and overlap between A10 and TFR (Fig. S2 B) 
was 0.41 ± 0.11. These results suggest a high probability of 
colocalization of portions of A10 with PS at the cell surface, as 
expected from our biotinylation experiments (Fig. 2 D).
We performed superresolution imaging using SIM on our 
untransfected 7W cells. Consistent with our confocal data, SIM 
detected partial colocalization between A10 and PS1 at much 
higher resolutions (Fig. 6 B, orthogonal rendering after Imaris 
processing). We observed punctate staining of endogenous A10 
and PS1 immunoreactivity throughout the cell body; however, 
the majority of colocalization occurred near the periphery of 
the cell, near the cell surface (Fig. 6 C, large view; Fig. 6 D, 
magnified image of inset in C; and Fig. 6 E, 3D rendering of C 
by Imaris). Next, we examined A10 and PS1 immunolocaliza-
tion using SIM in intact hippocampal cryosections from young 
adult (3 mo old) C57BL/6 WT mice. SIM for PS1 and A10 in 
the stratum radiatum of the hippocampus revealed a punctate 
pattern (Fig. S2 D) that also colocalized with the postsynap-
tic marker Homer (not depicted), suggesting that A10 and 
PS1 may coexist at synaptic membranes. As a control, we also 
examined the colocalization of TFR with PS1 (Fig. S2 E) on 
the same brain tissue samples. To quantify colocalization be-
tween A10 and PS1, we analyzed images using Imaris and MAT 
LAB (see SIM section of Materials and methods). Analysis of 
the 3D SIM images revealed that 11.8% of total cellular A10- 
immunoreactive puncta colocalized with PS1-immunoreactive 
puncta versus 4.8% of total TFR-immunoreactive signal (Fig. 
S2 F). Therefore, our data using superresolution SIM demon-
strate that a portion of A10 colocalizes with PS1 in cultured 
cells and in intact mouse brain tissue.
As a third imaging method to demonstrate colocalization, 
we measured the fluorescence lifetime of PS1 labeled with an 
Alexa Fluor 488 donor fluorophore in the absence or presence 
of A10 stained with a Cy3 acceptor fluorophore. Fluorescence 
lifetime imaging microscopy (FLIM) can be used to determine 
protein–protein proximity with <10 nm resolution (Lleó et al., 
2004). When endogenous PS1 in 7W cells was labeled with 
Alexa Fluor 488 in the absence of an acceptor, we observed 
a lifetime of ∼2,387 ± 39 ps, similar to what has been previ-
ously reported (Herl et al., 2009). In the presence of the CY3 
Figure 4. A10 exists with γ-secretase in an HMW complex isolated from normal brain by SEC. (A) WT mouse brain microsomes were fractionated on a 
Superose 6 column and blotted with antibodies to the indicated proteins. (B) Mouse brain microsome fractions from a Superose 6 column were pooled 
into HMW or LMW fractions and immunoprecipitated for A10 and then probed for A10 and coIP of NCT and PS1 CTF. The asterisks indicate nonspecific 
bands. (C) S20 cells were lysed in 0.25% DDM, loaded onto a BN-PAGE, and probed for A10 and γ-secretase. (D) 7W cells transfected with control or 
A10 siRNA were analyzed as in C. im, immature; m, mature.
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acceptor (on A10), we observed a shortening of the Alexa Fluor 
488 lifetime to 2,186 ± 91 ps, resulting in a fluorescence res-
onance energy transfer (FRET) efficiency of 8.4 ± 3.8% and 
thus demonstrating close atomic proximity (<10 nm) between 
some PS1 and A10 molecules and supporting our other ex-
tensive morphological and biochemical evidence that the 
two proteins can interact.
γ-Secretase inhibition, but not modulation, 
induces a feedback mechanism that 
activates A10-mediated α-secretase 
processing and concomitantly reduces 
β-secretase processing
We next asked whether our identification of endogenous, 
proteolytically active α–γ-secretase complexes in normal 
cells and brain might be associated with a functional con-
sequence of inhibiting γ-secretase on the processing of sub-
strates by α-secretase. Upon treating 7W CHO cells, which 
express human APP but only endogenous α- and γ-secre-
tases, with the γ inhibitor DAPT, we observed a robust in-
crease in APPs-α levels in their conditioned media (CM; 
Fig. S3 A). This increase in APPs-α was presumably the 
result of an α-secretase, as a general metalloprotease inhib-
itor (TAPI-I) ablated the increase (Fig. S3 A). To determine 
which α-secretase was responsible for this apparent feedback 
mechanism, siRNAs targeting ADAM9, A10, or TACE were 
transfected into the 7W cells. Knockdown of endogenous 
A10 largely prevented the increase in APPs-α seen upon γ 
inhibition (Fig. S3 B, quantified in C), whereas knockdown 
of endogenous ADAM9 or TACE did not, indicating that A10 
was the responsible α-secretase.
Next, we sought to confirm these results in cells that also 
do not overexpress APP. When untransfected human M17D 
cells were treated with DAPT, γ-secretase was inhibited (ro-
bust increase in APP CTFs) and the APPs-α in the CM was 
significantly elevated (Fig. S3, D and E); this effect occurred 
without any significant change in the levels of endogenous full-
length APP and mature and immature A10 and PS1 (Fig. S3 
D). In these experiments, we observed a concomitant decrease 
in APPs-β levels, thereby elevating the ratio of APPs-α/APPs-β 
significantly after DAPT treatment (Fig. S3 E).
To rigorously confirm this intriguing finding, we tested 
a range of additional γ-secretase inhibitors, including some 
that have been studied in human (AD) trials. γ-30 cells were 
treated with DAPT, Avagacestat (BMS-708136), Begacestat 
(GSI-953), BMS-299897, Semagacestat (Lilly L450139), and 
three different Notch-sparing γ-secretase inhibitors synthesized 
in our center (AD1112, AD1113, and AD1138; Fig. 7 A). We 
assayed the APPs’ secretion into the CM by WB and by ELI 
SA. Almost all the γ inhibitors robustly inhibited γ-secretase 
activity (as shown by a substantial increase in APP CTF levels), 
and they simultaneously enhanced the generation of APPs-α 
Figure 5. The coimmunoprecipitated α–γ-complex contains both α- and γ-secretase proteolytic activities. (A) S20 lysates were immunoprecipitated for 
A10, PS1, or just PAA. The immunoprecipitates were subjected to a γ-secretase activity assay (see Activity assays in Materials and methods) using a C100-
Flag APP substrate. γ-Secretase activity was documented by generation of both AICD and Aβ via WB (left). The AICD generation was quantified (right). 
(B) S20 lysates were immunoprecipitated for γ-secretase using M2 (to Flag-Pen2) or 3F10 (to Aph-1-HA) and as controls TFR or M2 preabsorbed with Flag 
peptide. α-Secretase activity assays were performed on the resin using a fluorogenic peptide substrate (left) and quantified (right). A one-way ANO VA with 
Tukey’s posttest for multiple comparisons was used. *, P < 0.05. n = 6. After the activity assays, the immunoprecipitates were eluted and blotted for coIP 
of A10, NCT, and PS1 NTF. Error bars indicate the SD. im, immature; m, mature.
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(Fig. 7 A, quantified in B). Interestingly, Semagacestat in our 
hands did not robustly inhibit γ-secretase; in agreement, the re-
sulting increase in APPs-α was much lower than with the other 
inhibitors. AD1113 produced no inhibition of γ-secretase and 
likewise did not result in increased APPs-α. When the levels of 
γ inhibition (i.e., degrees of increase in APP CTF levels) were 
plotted against the levels of APPs-α generation, we observed 
a correlation coefficient of 0.86 (Fig.  7  D), showing that the 
level of γ-secretase inhibition was highly correlated with the 
corresponding level of APPs-α secreted. When we assayed for 
APPs-β in the same CM by ELI SA (Fig. 7 C), γ inhibition pro-
portionately reduced APPs-β levels, suggesting that the increase 
in α processing is at the expense of β-secretase processing. We 
confirmed all of these inhibitor effects in γ-30 cells in our 7W 
cell line that expresses only endogenous levels of both α- and 
γ-secretase (unpublished data). Collectively, these data strongly 
suggest that there is a robust functional cross-regulation be-
tween γ-secretase activity and both α-secretase and β-secretase 
activity, further supporting our overall hypothesis that the secre-
tases play interconnected physical and functional roles in the 
physiological processing of substrates.
To determine whether a γ-secretase modulator also af-
fected APPs-α or -β secretion similar to γ inhibitors, we treated 
7W cells with the canonical and well-characterized γ-secretase 
modulator, sulindac sulfide. As expected, treatment with 50-µM 
sulindac sulfide significantly reduced the Aβ42/40 ratio to 7%, 
from 10% (Fig. S4 B); however, this treatment did not affect 
the levels of APPs-α secretion by WB (Fig. S4 A) nor alter the 
APPs-α/-β ratio by ELI SA (Fig. S4 C).
We next asked whether AD-causing mutations in PS1 
could themselves alter the amount of APP shedding by α- or 
β-secretase. HEK293 cells stably expressing WT APP plus 
either WT PS1 or familial AD (FAD)–causing PS1 mutations 
(M146L, L392V, or Y115H; Citron et al., 1997) showed that 
each mutation significantly increased the Aβ42/40 ratio in the 
CM well above the normal ∼0.15 ratio of WT cells as expected 
(Fig. S4 D). Quantifying the levels of APPs-α and APPs-β by 
ELI SA revealed no significant difference between WT PS1 and 
any of the PS1 mutant lines (Fig. S4 E).
γ-Secretase inhibition does not alter the 
association between A10 and γ-secretase 
but instead leads to increased cell surface 
presentation of APP and BACE1
To further explore the mechanistic basis of the positive feed-
back on the α-secretase processing of substrate by inhibiting 
γ-secretase, we asked whether γ inhibition increased the phys-
ical association between γ-secretase and A10. S20 cells were 
Figure 6. Confocal microscopy and SIM of A10 and γ-secretase in 7W cells. (A) A 1-μm optical section of 7W cells stained for A10 (green), PS1 (red), 
and Hoechst by confocal microscopy (left). Individual channel image for A10 (green, top right) and PS1 (red, bottom right). (B) Orthogonal view of 
SIM image showing colocalization (yellow) of some A10 (green) and PS1 (red) immunoreactive puncta in 7W cells. (C) Superresolution SIM images of 
A10 (green) and PS1 (red) immunoreactive puncta in 7W cells. (D) Magnified image of inset in C. (E) 3D-rendered image of D by Imaris processing. 
Bars: (A) 20 µm; (B) 2 µm; (C) 4 µm; (D and E) 3 µm.
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treated with DAPT, immunoprecipitated for γ-secretase with 
M2 resin (to Flag-Pen2), and blotted for A10 (Fig. S5 A). Al-
though DAPT treatment again increased the levels of APPs-α 
secretion (Fig. S5 B), it did not change the association between 
mature A10 and mature γ-secretase.
As yet another approach to examine the mechanism of 
the γ→α feedback, we asked whether the cell surface pre-
sentations of A10, γ-secretase, BACE1, or the APP substrate 
were altered by γ inhibition. 7W cells were treated with DAPT 
or DMSO, and 24 h later they were treated with a non–cell 
permeant biotinylation reagent, lysed, and pulled down with 
streptavidin to enrich for cell surface proteins (Fig. 8 A). γ in-
hibition did not alter the cell surface levels of mature γ-secre-
tase (i.e., PS1 CTF and mature NCT), mature A10 (immature 
A10 was not biotinylated as expected, providing an excellent 
control for the specificity of our intact-cell surface labeling), 
or the canonical recycling protein TFR (Fig. 8 A), whereas 
it again substantially increased APPs-α levels in the medium 
(Fig. 8 B). In contrast, the levels of APP at the cell surface 
were elevated to 184 ± 45% of the control (DMSO) by the 
Figure 7. Multiple structurally diverse γ-secretase inhibitors regulate processing by α- and β-secretase. (A) γ-30 cells were treated with various γ inhibitors 
for APP, and the CM and lysates were analyzed for the indicated proteins. (B) Western blot quantification of APPs-α was performed on CM samples from 
A, normalized to total APP levels in the lysate, and then normalized to DMSO-treated control samples. A one-way ANO VA with Dunnett’s posttest using 
DMSO as the control was performed. n = 6. (C) APPs-β ELI SA was performed and quantified. All samples were equalized for APP levels, normalized 
to the DMSO-alone sample, and then analyzed by the same statistical test as in B. n = 4. (D) Levels of APP CTFs in lysates were plotted against APPs-α 
levels in CM (from Fig. 8 A) and fitted with a linear regression line. n = 36 from two independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 
0.001; ****, P < 0.0001.
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DAPT treatment (Fig. 8 A, quantified in C). This consistent 
finding could explain why α-secretase cleavage of APP was 
increased at the expense of β-secretase, because α-secretases 
have been shown to cleave substrates (including APP) prefer-
entially at the cell surface (Koo et al., 1996; Gutwein et al., 
2003). Interestingly, we found that levels of BACE1 at the cell 
surface were also elevated to 179 ± 40% of the DMSO control 
by γ inhibition (Fig. 8 A, quantified in C). Because BACE1 
is an aspartyl protease and works optimally in acidic pH of 
early and late endosomes, BACE1 processing of APP should 
be decreased by this enhancement of BACE1 levels at the 
plasma membrane (i.e., neutral pH), and that is just what we 
had documented (Fig. 7 C). γ inhibition did not significantly 
affect the total levels of APP in the lysate but did slightly in-
crease BACE1 levels to 129 ± 23% of DMSO-treated con-
trol (Fig. 8 A, quantified in D). This stabilization of BACE1, 
however, cannot explain the much larger increase in the sur-
face localization of BACE1. Collectively, these mechanistic 
experiments suggest that acute pharmacological inhibition of 
endogenous γ-secretase increases the total levels of mature 
BACE1 and particularly increases the levels of mature APP 
and BACE1 at the cell surface, thus enhancing APPs-α shed-
ding at the expense of APPs-β without altering the surface lev-
els of A10 and γ-secretase.
Figure 8. Inhibition of γ-secretase activity increases the cell surface presentation of APP and BACE1. (A) Top: 7W cells were treated with DAPT, and cell 
surface proteins were labeled with a non–cell permeable biotinylation reagent. Lysates from the biotinylated cells were pulled down with streptavidin. 
Whole lysates (left) and cell surface proteins (right) were probed for the indicated proteins. (B) CM from A were analyzed for APPs-α and total APPs by 
WB. (C) Surface levels of APP and BACE were quantitated from A and normalized to total APP or BACE levels in the lysate, respectively. A two-way ANO 
VA with a Sidak’s posttest was performed. ****, P < 0.0001. n = 8. (D) Total lysate levels of APP and BACE were quantitated from A and normalized to 
total protein concentration. A two-way ANO VA with a Sidak’s posttest was performed. ***, P < 0.001. n = 8. im, immature; m, mature.
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Select tetraspanin (TSP AN) proteins help 
mediate the stability and function of the 
α–γ-secretase complex
The TSP AN web has been extensively implicated in the stabil-
ity and activity of A10 and separately for γ-secretase (Arduise 
et al., 2008; Wakabayashi et al., 2009; Xu et al., 2009; Dunn 
et al., 2010; Dornier et al., 2012; Haining et al., 2012; Prox 
et al., 2012). Specifically, TSP AN12 and the TSP AN C8 fam-
ily (TSP AN5, 10, 14, 15, 17, and 33) have been reported to 
be important for A10 stability, localization, and activity. We 
sought to determine whether these candidate TSP ANs may 
play a role in the α–γ-complex we have identified. siRNA- 
mediated knockdown of TSP AN5 and 14, or else of TSP AN12 
and 17 (T10, T15, and T33 are not expressed in our CHO-based 
cells; unpublished data), were each able to reduce APPs-α se-
cretion (Fig. 9 A, bottom). TSP AN12 and 17 knockdown did 
not affect A10 levels or maturation, whereas TSP AN5 and 14 
knockdown decreased A10 maturation and increased the lev-
els of immature A10 (Fig. 9 A). Next, we sought to determine 
whether knocking down these candidate TSP ANs would affect 
the A10–γ-secretase interaction. S20 cells were transfected with 
siRNAs targeting TSP AN5 + 14, TSP AN12 + 17, or all four 
and were then immunoprecipitated for γ-secretase (via Pen-2) 
and probed for the coimmunoprecipitate of A10 (Fig. 9 B). We 
saw that knockdown of these two pairs of TSP ANs consistently 
reduced the level of coIP of mature A10. Although there was 
less coIP of A10 upon TSP AN5 + 14 knockdown, there were 
also reduced levels of mature A10 in the total lysate, making 
it difficult to conclude whether the observed reduction in coIP 
from this pair was the result of a decrease in the association 
of A10 with γ-secretase or just a result of the reduced levels 
of A10 protein. In contrast, knockdown of TSP AN12 + 17 did 
not reduce the total cellular levels of mature A10 but still re-
duced the degree of coIP with γ-secretase, suggesting that this 
pair of TSP ANs in particular is important for α–γ-complex for-
mation and/or stability.
In light of this intriguing result, we sought to determine 
whether the TSP ANs that help mediate α–γ-complex assembly 
are also involved in the γ→α feedback mechanism. 7W cells 
were first transfected with TSP AN12 + 17 siRNAs as in Fig. 9 B 
and were then treated with increasing doses of DAPT (Fig. 9 C), 
and their CM were analyzed for the APPs-α/APPs-β ratio by 
ELI SA (Fig. 9 D). Treatment with increasing doses of DAPT 
resulted in an increase in APP CTFs, demonstrating a dose-de-
pendent inhibition of γ-secretase as expected (Fig. 9 C). In con-
trol samples (no TSP AN knockdown), the APPs-α/-β ratio at 
the maximal dose of DAPT tested (1 µM) resulted in a 4.8-fold 
increase above the DMSO-treated control. Knockdown of TSP 
AN12 + 17 reduced baseline APPs-α levels as before (Fig. 9 C, 
see lowest doses of DAPT used), but there was a reduction of 
the APPs-α/-β ratio at the maximal dose of DAPT (1 µM) to just 
3.8-fold above the DMSO control. Likewise, the differences in 
the dose–response curves were significant at the 0.033-µM and 
0.1-µM DAPT concentrations (Fig. 9 D). In other words, DAPT 
at a particular dose was less effective in raising the APPs-α/-β 
ratio after a TSP AN12 + 17 knockdown that decreases the as-
sociation of α- and γ-secretases in cells. The levels of A10 and 
PS1 were not affected by both TSP AN12 + 17 knockdown and 
DAPT (Fig. 9 C). Together, these integrative data suggest that 
manipulating TSP AN12 and 17 alters the γ→α-/β-secretase 
feedback mechanism when it simultaneously destabilizes the 
A10–γ-secretase complex.
Coordinate processing by complexes of a 
sheddase and an intramembrane protease 
may represent a general model extendable 
to the β- and γ-secretases
Finally, we asked whether the new cell biological model of RIP 
described thus far could be generalized to β-secretase. To this end, 
we probed whether β-secretase also interacts with γ-secretase. 
Microsomes from WT mouse brains, which have high endoge-
nous expression of BACE1 (β-secretase), were immunoprecipi-
tated for endogenous PS1 CTF and blotted for the coIP of BACE1 
(Fig. 10 A). IP of PS1 CTF brought down endogenous BACE1, 
indicating that β-secretase can also interact with γ-secretase. 
Importantly, this finding was also observed in the reverse di-
rection, in that several BACE1 antibodies (Fig. 10 B) were each 
able to coimmunoprecipitate endogenous PS1 CTF, whereas no 
significant coIP with TFR occurred. The results demonstrate that 
endogenous β-secretase, like α-secretase, can interact with en-
dogenous γ-secretase in a multisecretase complex.
We examined whether α- and β-secretase interacted with 
γ-secretase in the same complex or in distinct complexes. To this 
end, we performed IPs for A10 (Fig. 10 C) or BACE1 (Fig. 10 D) 
and blotted for the coIP of BACE1 or A10, respectively. IP of A10 
or BACE1 did not bring down detectable amounts of the other 
sheddase. This consistent result indicates that we were unable to 
detect A10 and BACE1 interacting together in a super complex 
and that they may each form separate complexes with γ-secretase.
Discussion
Here, we provide multiple lines of experimental evidence that the 
processing of membrane proteins by the α- and γ-secretases can 
occur within a single, multiprotease complex. We establish that 
the principal α-secretase, A10, associates with γ-secretase in a 
larger functional complex. Further, we demonstrate that this is 
extendable to β- and γ-secretases, as BACE1 was shown to asso-
ciate endogenously with γ-secretase. It is possible that other in-
tramembrane proteases such as S2P and signal peptide peptidase 
may also associate with their respective sheddases. Indeed, our 
preliminary data indicate that S2P can associate with S1P (unpub-
lished data), suggesting that this new model may be relevant to the 
biological mechanism of RIP by other intramembrane proteases.
A10 and γ-secretase interact at both overexpressed and 
endogenous levels and at a site—the plasma membrane—where 
each has been well documented to be active. We also observed 
an interaction between TACE and γ-secretase; indeed, as an 
important control for specificity, this interaction was not seen 
in neural cells or mouse brain, where abundant immature but 
little mature TACE is present. Thus, the precise composition 
of the heteromeric α–γ-secretase complexes we describe may 
be cell type dependent. By SEC, mature A10 fractionated with 
mature γ-secretase in an HMW complex, and the two endoge-
nous secretases could be coimmunoprecipitated from such frac-
tions of normal mouse brain. Furthermore, A10 and γ-secretase 
co-migrated in an HMW complex of ∼440 kD by BN-PAGE.
Importantly, we found that the α–γ-complex is functional, 
as both α- and γ-secretase proteolytic activities were recovered 
by coimmunoprecipitating either secretase. In addition to physical 
and functional interactions, we observed an unexpected and robust 
increase in the α-secretase shedding of APP upon γ inhibition. 
This quantitative and highly significant correlation (r = −0.86) 
was documented with multiple γ inhibitors, including some used 
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Figure 9. TSP AN12 and 17 are required for A10 and γ-secretase association and contribute to the α–β-secretase activity regulation by γ inhibition. 
(A) 7W cells were transfected with siRNA targeting TSP AN5 + 14, TSP AN12 + 17, or the control. CM were analyzed for APPs-α and lysates for A10 and 
PS1. (B) S20 cells were transfected with siRNA as in A, and the resultant lysates were immunoprecipitated for γ-secretase by pull-down of Flag–Pen-2 (via 
an M2 resin). The resulting immunoprecipitates were probed for the coIP of A10 and other γ components. (C) 7W cells were transfected with control siRNA 
or siRNA targeting both TSP AN12 and 17 and treated in duplicate with increasing amounts of DAPT (3 nM–1 µM). The resulting CM was probed for 
APPs-α and lysates for A10, PS1, and APP CTFs. (D) CM from C was analyzed by an MSD ELI SA for APPs-α and APPs-β. Data are represented as a ratio of 
APPs-α/APPs-β. A two-way ANO VA with a Sidak’s posttest was performed. *, P < 0.05; ***, P < 0.001. n = 6. CON, control; im, immature; m, mature.
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in AD clinical trials: Begacestat, Avagacestat, and Semagacestat. 
The highly consistent increase in α-secretase processing of APP 
upon γ inhibition occurred at the expense of β-secretase process-
ing. Mechanistically, the stimulatory effect of γ inhibition on 
APP shedding is a result, at least in part, of substrate trafficking, 
as γ inhibition enhanced levels of APP (and BACE1) at the cell 
surface. Both γ modulators (which do not abrogate γ-secretase 
cleavage per se) and FAD mutations in PS1 did not consistently 
alter α-secretase activity.
Collectively, our findings have implications for the fun-
damental biology of the secretases in cells. We observed spe-
cific interactions of A10 and of BACE1 with γ-secretase but 
could not coimmunoprecipitate the three proteases together 
in a supercomplex. It thus becomes important to determine 
whether BACE1, A10, and TACE each occur in distinct com-
plexes with γ-secretase, analogous to how PS1 and PS2 as well 
as the three principal isoforms of Aph-1 can each form distinct 
complexes with the other proteins of γ-secretase (De Strooper, 
2003; Hébert et al., 2004; Shirotani et al., 2004). We hypoth-
esize that the complexes we have identified may be cell type 
dependent, explaining why in some cells, certain coIPs were 
not observed (e.g., in neural M17D cells, TACE did not coIP 
with γ-secretase, probably because TACE exists exclusively in 
its immature form). This hypothesis may be relevant to the long 
and growing list of γ-secretase substrates, as there may exist 
several different cellular complexes composed of different vari-
ations of sheddases and γ-secretases that are each responsible 
for processing a subset of substrates for reasons of substrate 
structure or subcellular localization. Multiple γ-complexes 
comprising various PS and Aph-1 isoforms have been identified 
and reconstituted (Hébert et al., 2004; Shirotani et al., 2004). 
Whether these γ-complexes interact differentially with the vari-
ous α- and β-secretases now becomes important to answer. De-
spite our negative results to date, we cannot exclude that both 
BACE1 and A10 can sometimes form a single large complex 
with γ-secretase in certain subcellular compartments. This 
could explain why α- and β-secretases sometimes compete with 
each other for processing of substrates. Also, it has been shown 
that α-secretase (A10) may efficiently cleave C99 under endog-
enous conditions (Kuhn et al., 2010), and we found evidence of 
such processing in our A10 coIP activity assays (Fig. 5 A). But 
under endogenous conditions, we have so far not identified an 
interaction between BACE1 and A10.
Although several screens have been performed to identify 
novel γ interactors, none to our knowledge has identified A10 or 
BACE1 (Zhou et al., 2005; Wakabayashi et al., 2009; Hur et al., 
2012; Teranishi et al., 2012). The degree of coIP between A10 or 
BACE1 and γ-secretase in our study was not as high as the coIP 
of the four canonical members of the γ-complex, which could ex-
plain the prior lack of identification of α-secretase as a γ interactor. 
Figure 10. BACE1 also interacts with γ-secre-
tase but not with A10. (A) CHA PSO-solubilized 
mouse brain microsomes were immunoprecipi-
tated for PS1 CTF or using control resin. Immu-
noprecipitates were probed for PS1 NTF and 
for the coIP of BACE1. (B) Mouse brain micro-
somes solubilized in 1% CHA PSO were immu-
noprecipitated for BACE1 or TFR and probed 
for the coIP of PS1 CTF. (C and D) Mouse brain 
microsomes were immunoprecipitated for A10 
(C) or BACE1 (D) and probed for the coIP of 
BACE1 or A10, respectively. Con, control; 
im, immature; m, mature.
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One probable explanation that our mechanistic data support 
is that the α–γ- and β–γ-secretase interactions are indirect and 
occur within a larger multiprotein complex to finely regulate 
substrate processing. Although we used multiple methods (coIP, 
biochemical cofractionation, native PAGE, superresolution mi-
croscopy by SIM, and FLIM) and examined multiple cell/tissue 
sources to obtain clear evidence that an α–γ interaction does 
occur endogenously, we also obtained evidence that this interac-
tion is indirect, i.e., mediated by other scaffolding partners like 
the TSP AN. Specifically, we demonstrate here that TSP AN5 and 
14 can affect both the maturation and activity of A10 and that 
TSP AN12 and 17 affect A10 activity without detectably altering 
A10 maturation; however, both sets of TSP ANs were shown to 
mediate, in part, the association between A10 and γ-secretase.
A10 has previously been shown to be a substrate of RIP 
processing by γ-secretase (Tousseyn et al., 2009). We provide 
several lines of evidence here that the interaction between A10 
and γ-secretase that we describe is not simply that of a substrate 
(A10) and a protease (γ-secretase) but represents a functional, 
biologically relevant complex. First, under endogenous expres-
sion levels, predominantly the mature forms of the secretases in-
teract with each other. This was particularly well seen in normal 
mouse brain tissue, where principally mature A10 was found 
to interact with mature γ-secretase (Figs. 2 and 3). Second, we 
document an interaction at the plasma membrane, where both 
mature secretases are known to reside and to process numer-
ous substrates (Fig. 2 D). Third, we observed that the complex, 
upon coIP, contains both α- and γ-secretase cleavage activities 
(Fig.  5). Fourth, we observed what appears to be sequential 
processing by α- and γ-secretase of a canonical APP substrate 
(Fig. 5 A). In the presence of the immunoisolated α–γ-complex, 
a fragment corresponding to C83 was generated from C100 (i.e., 
C99 with a translation-initiating methionine), and this C83 gen-
eration was inhibited by TAPI-I, consistent with it arising from 
α processing. Moreover, this C83 fragment was stabilized by a 
γ inhibitor, suggesting that it is further processed by γ-secretase 
to p3 and AICD, as expected. These experimental results are 
entirely consistent with sequential α- and γ-secretase process-
ing of C100. Lastly, we observed a stronger level of interaction 
between A10 and γ-secretase than APP and γ-secretase. In our 
γ-30 cells, which have overexpressed APP and high levels of 
γ-secretase, we saw a more robust coIP of γ-secretase with en-
dogenous A10 than with the overexpressed APP (Fig. 2 A; com-
pare the enrichments of APP vs. A10 and vs. TACE). Together, 
these data support our hypothesis that A10 and γ-secretase re-
side in a higher molecular weight complex that is capable of 
accepting full-length substrates for sequential processing.
Beyond the physical interaction between the secretases, 
we provide evidence that the cleavages mediated by these ubiq-
uitous proteases are much more functionally interconnected 
than previously believed. Our finding that pharmacological in-
hibition of γ-secretase increased α-secretase processing of APP 
(Figs. 7 and S3) could explain a report that prolonged treat-
ment of humans with Semagacestat modestly elevated levels of 
APPs-α in the CSF and also significantly increased an α-secre-
tase product of C99, Aβ16 (Portelius et al., 2010). Moreover, a 
recent publication demonstrated that a FAD mutation in the γ 
cleavage region of APP resulted in an increase in APPs-β secre-
tion, and this increase was prevented by a γ inhibitor (Muratore 
et al., 2014), consistent with our model of cross talk within a 
functionally interconnected secretase network. A practical out-
come of our work here is that future studies examining the effects 
of γ-secretase inhibitors, including those in clinical trials for 
AD or cancer, should closely examine their effects on α- and 
β-secretase processing, which could lead to unwanted side ef-
fects. Furthermore, we establish that this feedback mechanism 
is dependent at least in part on the α–γ-complex, as weakening 
of this complex by selective knockdown of TSP AN12 and 17 
simultaneously reduced the feedback of γ inhibition on α- and 
β-secretase processing of a canonical substrate.
Mechanistically, the enhancement of APP shedding by 
pharmacological γ inhibition is likely a result of the increase 
this caused in the cell surface presentation of mature APP, where 
A10 predominantly cleaves its substrates (whereas BACE1 
predominantly cleaves substrates in acidic environments like 
recycling endosomes). This phenomenon has been previously 
suggested, in that cells expressing a catalytically inactive form 
of PS1 had enhanced retention of APP (and presumably many 
other substrates) at the cell surface (Kaether et al., 2002). We 
also observed an increase in BACE1 at the cell surface, but, not 
unexpectedly, we did not see an increase in β-secretase process-
ing of APP. At least two factors could explain the latter finding. 
First, BACE1 is an aspartyl protease that cleaves optimally at 
pH 4.5 in vitro (Vassar et al., 1999). Thus, the neutral pH found 
at the cell surface is not optimal for BACE1 activity. Second, 
the increase in BACE1 on the plasma membrane is likely a re-
sult of the retention of mature BACE1 at the cell surface and not 
because of increased trafficking of BACE1 from the ER to the 
surface, as immature BACE1 remained unchanged. The BACE1 
molecules that are prevented from being endocytosed into en-
dosomes are thus retained in a compartment where they cannot 
efficiently process substrates. It is likely that these previously 
unrecognized trafficking effects arising from γ inhibition occur 
with other substrates besides the canonical γ substrate, APP.
In summary, our numerous biochemical and cell bio-
logical findings provide new directions for future research on 
the mechanism of RIP in health and disease: (a) the data on 
α–γ- versus β–γ-complexes suggest the occurrence of distinctly 
composed multisecretase complexes that may have specialized 
functions for processing some but not other substrates; (b) our 
inhibitor experiments uncover an unexpected and robust regu-
lation of α-secretase activity by γ-secretase activity, a cross talk 
that was not anticipated but needs to be known to predict poten-
tial side effects of chronically inhibiting γ-secretase in cancer 
and AD; (c) in contrast to γ-secretase inhibitors, γ-secretase 
“modulators” do not trigger this cross-regulation, supporting 
their clear advantage for human therapy; (d) collectively, the 
extensive data herein support a new cell biological model of 
RIP in which the sheddase and the intramembrane protease re-
side together in a higher molecular weight complex mediated in 
part by select members of the TSP AN and capable of accepting 
full-length transmembrane substrates and processing them to 
their end products rapidly and efficiently.
Materials and methods
Reagents, cell culture, inhibitor treatments, and transfections
All siRNAs were obtained from the siGenome series (GE Health-
care) of siRNAs (Table  1). All constructs ordered were pools of 
four sequences per target.
DAPT was purchased from Sigma-Aldrich, whereas all other in-
hibitors were synthesized in-house and given to us by C. Augelli-Szafran 
(Brigham and Women’s Hospital, Boston, MA). Sulindac sulfide was 
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purchased from Sigma-Aldrich. Our 7W, PS70, γ-30, and S20 CHO 
cell lines were cultured as previously described (Kimberly et al., 2003; 
Cacquevel et al., 2008). In general, cells were maintained in DMEM 
plus 10% FBS, 2-mM l-glutamine, 100 µg/ml streptomycin, and 100 
U/ml penicillin, plus the appropriate selection antibiotic for each line. 
For inhibitor treatments, cells were conditioned for 4–16  h in Op-
ti-MEM media (Gibco) with inhibitors at the following concentrations: 
500-nM DAPT, 25-M TAPI-I, 15-nM BMS-708163 (Avagacestat), 
150-nM Wyeth GSI-953 (Begacestat), 75-nM BMS-299897, 200-nM 
Lilly 450139 (Semagacestat), 350-nM AD1112, 30-nM AD1113, and 
50-nM AD1138. For transient transfections, Lipofectamine 2000 (In-
vitrogen), Fugene 6, or Fugene HD (Roche) were used to transfect 
cDNAs into cells according to the manufacturer’s standard protocol. 
Cells were harvested 24 h after transfection. For siRNA transfections, 
Lipofectamine RNAiMAX (Invitrogen) was used to transfect 50-nM 
siRNA into cells. Cells were harvested 48 h after transfection.
Sample preparation and IP
Whole cell lysates and microsomes were prepared as previously de-
scribed (Chen et al., 2010). In brief, 10-cm culture plates were first 
washed with PBS and then lysed in 1 ml of 50-mM Hepes buffer + 
150-mM NaCl containing either 1% CHA PSO, 1% digitonin, 0.25% 
DDM, or 1% NP-40, as stated. In some cases, 10-mM 1,10-phenanth-
roline was included in the lysis buffer. The lysates were then incubated 
on ice for 30 min and spun at 14,000 rpm on a tabletop microfuge 
to pellet insoluble material. For microsome preparations, cells were 
first Dounce homogenized with a tight pestle in TBS containing no 
detergent, followed by passage through a 27.5-gauge needle four times. 
Samples were then centrifuged at 1,000  g followed by a 100,000  g 
ultracentrifuge spin to pellet microsomes, which were solubilized in 
50-mM Hepes buffer + 150-mM NaCl containing 1% of the detergent 
mentioned for 60 min, followed by another 100,000  g spin. Protein 
concentrations were determined for both lysates and microsomes by 
a bicinchoninic acid protein assay (Thermo Fisher Scientific), and all 
samples were normalized for equal concentration before experiments.
For immunoprecipitates, 0.8–1.5 mg of cell lysates or micro-
somes in 0.8–1.0-ml volumes of lysis buffer were precleared with pro-
tein A or G agarose for 90 min before IP. The immunoprecipitates were 
incubated overnight at 4°C and then washed three times in lysis buffer. 
The immunoprecipitated proteins were then eluted in SDS sample buf-
fer. For the IP of tagged proteins, we used 3F10 resin (rat; Roche), 
HA7 resin (mouse; Sigma-Aldrich), Myc resin (rabbit; Sigma-Al-
drich), and M2 resin (mouse; Sigma-Aldrich) for Flag-tagged proteins 
and V5 resin (mouse; Sigma-Aldrich). For IP of all other proteins, pro-
tein A or protein G agarose were added with antibodies targeting the 
specific protein. For A10 IPs, we used antibody 422751 (rabbit; EMD 
Millipore), 19026 (rabbit; EMD Millipore), 124695 (rabbit; Abcam), 
or 73402 (mouse; Abcam). For TACE, we used the rabbit antibodies 
ab75609 or ab2501 (both from Abcam). Rabbit antibody X81 (Xia et 
al., 1997a), directed against the first 81 residues of PS1, was used to 
IP PS1 NTF. For PS1 CTF, MAB5232 (mouse; EMD Millipore) and 
mouse antibody 13A11 (gift from Elan, plc, South San Francisco, CA; 
directed against the loop region of PS1) were used. Antibody ab84036 
(rabbit; Abcam) and a mouse monoclonal antibody from Invitro-
gen were used to IP TFR. BACE1 antibodies 195102, 195111 (both 
Calbiochem and both rabbit), AB5832 (rabbit; EMD Millipore), and 
MAB5308 (mouse; EMD Millipore) were used for IP. A commercial 
antibody (rabbit; Abcam) was used to IP NPR A.
For lysate-mixing experiments done as a negative control for our 
coIPs, the untransfected 7W cells were used as a source of γ-secretase–
negative cells (as they do not overexpress Flag–Pen-2 or human PS1), 
and S20 cells were used as γ-secretase–positive cells (as they do overex-
press all four γ-secretase components). For A10-negative and -positive 
cells, cells were transfected with either A10 siRNA (A10 negative) or 
control siRNA (A10 positive). The lysates were protein quantified and 
mixed at a 1:1 ratio, and then the mixture was immunoprecipitated with 
an M2 resin to the Flag tag on Pen-2 that is present only in the S20 cells.
Electrophoresis and WB
Samples were loaded onto 4–12% Bis-Tris gels using MES or MOPS 
running buffer (Invitrogen), transferred to nitrocellulose membranes, 
and probed for various proteins using standard WB. The resultant blots 
were detected with either an infrared imaging system (Odyssey; LI-
COR Biosciences) or by ECL and exposure to film.
The antibodies used to detect specific antigens were Flag tag, M2 
(mouse) and a rabbit polyclonal anti-Flag antibody (both from Sigma-Al-
drich); Myc tag, 9E10 (mouse) and A14 (rabbit; SCBT); HA tag, 3F10 
(rat; Roche); A10, 422751 (rabbit; EMD Millipore), ab19026 (rabbit; 
EMD Millipore), PC528 (rabbit; EMD Millipore), ab73402 (mouse; 
Abcam), and ab124695 (rabbit; Abcam); TACE, ab75609 (rabbit; 
Abcam), ab19027 (rabbit; EMD Millipore), AF2129 (goat; R&D Sys-
tems), and a rabbit C-terminal antibody provided by C. Blobel (Weill 
Cornell Medical College, New York, NY); APP, C7 (rabbit antibody 
targeting the last 20 amino acids in APP; Podlisny et al., 1991), 22C11 
(mouse; EMD Millipore), 6E10 (mouse; Covance), 1736 (rabbit; Haass 
et al., 1992), and two mouse monoclonal antibodies generated in-house 
that target either the APP ectodomain or C terminus (4F2 and 3F3, re-
spectively); Aβ, mouse monoclonal antibodies 2G3 and 21F12 that target 
the C-terminal of Aβ40 and 42, respectively (a gift from Elan, plc). For 
γ-secretase components, we used NCT, N1660 (rabbit; Sigma-Aldrich), 
and a monoclonal antibodie (BD); for PS1, we used 529591 (rabbit, 
EMD Millipore), MAB1563 (rat; EMD Millipore), MAB5232 (mouse; 
EMD Millipore), 13A11, and 4627 (rabbit antibody that targets the ex-
treme C terminus of PS1; Podlisny et al., 1997); and for Aph-1, we used 
O2C2 (rabbit; Thermo Fisher Scientific). For TFR, two antibodies from 
Invitrogen (H68.4; mouse) and Abcam (ab84036; rabbit) were used.
Table 1. Sequences of siRNA used to knock down respective targets
Target Sequence 1 Sequence 2 Sequence 3 Sequence 4
ADAM9 GCA AAGAG CUGUA UCAUGA GAG AUUAA CUAGA GAAAGA GAA CCAGA CUGCU GUGAGA GCA GAUCU CUUAC GUCAUC
ADAM10 GAA GGAAG CUUUA GUCAUG CCC AAAGU CUCUC AUAUUA GCA GAGAG AUACA UUAAAG GAA UUGCC CUGAU CAUGUU
ADAM17 GAA AGACA CUUCA AUAUGG UAU GGGAA CUCUU GGAUUA GGU AGCAG AUCAU CGAUUU UGA CCGAG UUGAU GACAUA
TSP AN5 GGA AUAAC GUUUC UUGGAA GCG AUGCG GUGUG CCAUUU GAU GAUUG GAACC UAAAUA CAU AGGCA UUGCA UUGCUA
TSP AN12 GGU CAGAU AUGGU UACUUU GAA CGUUA CUCGU CAUCUU GCG GUCAU CUUAA CUUACU CAU ACGAG CAGGA GGUUAU
TSP AN14 CAG CUACA AUAUC GUCUUU GAA CCUCA UUGAC UCCCUU GAA CAUCU GCCUG CUCAAG GGG AAUUC UUCGA GAGCAA
TSP AN17 GAU CCGAG ACCAA CUUAAU ACA ACAAU GUCAA AGCCUA GAA UACUG GUCUU GCUGUG UGA CAGAU CUGGG CGGUCU
CON TROL UAG CGACU AAACA CAUCAA UAA GGCUA UGAAG AGAUAC AUG UAUUG GCCUG UAUUAG AUG AACGU GAAUU GCUCAA
GE Healthcare siGEN OME is a pool of four individual siRNAs. Sequences 5′- to -3′ for the individual siRNAs are listed for each target.
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BN-PAGE
Cells were lysed in 50-mM Hepes buffer + 150-mM NaCl containing 
0.25% DDM detergent and incubated on ice for an hour. Lysates were 
first spun at 1,000 g for 5 min to pellet nuclei and large cellular debris, 
and this was followed by a 100,000 g spin for 60 min. DDM-soluble ly-
sates along with NativeMark protein standard (Invitrogen) were loaded 
onto a 4–16% Bis-Tris NativePAGE gel (Invitrogen) according to the 
manufacturer’s specifications. Gels were transferred to a polyvinylidene 
fluoride membrane and probed for the indicated proteins by WB.
Surface biotinylation
S20 cells were washed three times with PBS and then treated with 
sulfo-NHS-SS-biotin at 0.5–1.0 mg/ml for 30 min at room tempera-
ture or at 4°C if stated. Reactions were quenched with 1-M Tris (50-
mM final concentration) for 5 min and washed three times with TBS 
or PBS. Cells were lysed and immunoprecipitated for Aph-1 (HA7) 
or Pen-2 (M2) or alternatively, pulled down with streptavidin agarose 
as described and eluted with 1% SDS or sample buffer. Eluates from 
Aph-1 or Pen-2 immunoprecipitates were diluted 1:10 (final SDS con-
centration of 0.1%) and pulled down with streptavidin agarose (Sigma- 
Aldrich) overnight at 4°C. Pull-downs were washed, eluted with SDS 
sample buffer, and Western blotted.
SEC
Microsomes isolated from normal mouse brains or S20 cells were 
solubilized in 1% CHA PSO (250 µl of total volume), injected onto a 
Superose 6 10/300 column (24-ml-bed volume), and run on an fast pro-
tein liquid chromatography system (AKTA; GE Healthcare) in 50-mM 
Hepes buffer + 150-mM NaCl with 0.25% CHA PSO. 500-µl fractions 
were collected, concentrated, and analyzed by SDS-PAGE. In some ex-
periments, certain SEC fractions were pooled and concentrated before 
IP for A10, NCT, or Aph-1.
Activity assays
For γ-secretase activity assays, a C100-Flag substrate was used (Esler et 
al., 2002). In brief, all reactions were performed on resin in Hepes buf-
fer with 0.25% CHA PSO supplemented with 0.25 mg/ml phosphatidyl- 
ethanolamine, 1 mg/ml phosphatidylcholine, and 0.065 mg/ml choles-
terol. Reactions were incubated overnight at 37°C and terminated with 
SDS. Samples were then analyzed by WB or ELI SA for Aβ or AICD as 
a measure of γ activity. The addition of γ inhibitors was used to deter-
mine γ-secretase–specific activity.
For α-secretase activity assays, we used a fluorogenic peptide 
substrate (based on the sequence of pro-TNF) that is unquenched when 
cleaved (ES003; R&D Systems). Substrate was used at a concentra-
tion of 10 µM in 25-mM Tris, pH 8.0, 2.5-µM ZnCl, 0.25% CHA PSO, 
and 0.005% Brij 35 in a total volume of 150  µl and was incubated 
for 4  h at 37°C.  Reactions were stopped by adding EDTA and read 
on a florigenic plate reader with excitation at 320 nm and emission 
at 405 nm. α-Secretase–specific activity was measured as TAPI- 
I–inhibitable activity.
Immunocytochemistry
For immunocytochemistry, cells were fixed with 4% PFA + 4% sucrose 
followed by blocking and permeabilization with 2% normal donkey 
serum plus 0.1% saponin for 1 h. Primary antibodies targeting either 
A10 (1:200; ab1997, rabbit; Abcam), PS1 (1:1,000; 13A11, mouse), 
or TFR (both 1:200; ab84036, rabbit [Abcam]; H68.4, mouse [Thermo 
Fisher Scientific]) were incubated overnight at 4°C in blocking buffer. 
The following day, cells were washed with PBS and treated with sec-
ondary antibody for 1 h at a dilution of 1:2,000 in PBS followed by 
washes with PBS. Hoechst was included in the second to last wash 
at a dilution of 1:2,000. All slides were mounted with Vectashield 
mounting medium (Vector Laboratories). 1-μm optical sections were 
acquired on a microscope (LSM-710; Carl Zeiss) using a 63× oil im-
mersion objective. All images were processed and analyzed with Zen 
Black software (Carl Zeiss). To quantify colocalization, all images 
were stained together in the same session along with control samples 
where one or both primary antibodies were omitted (to calculate back-
ground fluorescence). Automated colocalization analysis of at least 
10 images (∼40 cells) was done with Zen Black software according 
to documented protocols.
Immunohistochemistry on mouse brain tissue
Immunohistochemistry was performed as described previously (Scha-
fer et al., 2012). In brief, 3-mo-old WT C57BL/6 mice were eutha-
nized and perfused with PBS via intracardiac perfusion. Brains were 
immersed in 4% PFA for 4  h at 4°C, followed by cryoprotection in 
30% sucrose/PBS for 48 h. 14-μm sagittal cryosections were cut from 
optimal cutting temperature compund–embedded brain blocks and 
stored at −80°C until staining. Slides were dried at 37°C for 20 min 
to remove condensation, washed twice in PBS, and then blocked with 
10% normal goat serum supplemented with 0.3% Triton X-100 for 2 h 
at room temperature. Primary antibodies were added at a concentra-
tion of 1:200 for A10 (PC528; EMD Millipore) and PS1 (13A11) or 
1:50 for TFR (ab84036) in blocking buffer overnight at 4°C. The next 
day, slides were washed three times in PBS for 10 min followed by 
appropriate Alexa Fluor–conjugated secondary antibodies at a dilution 
of 1:200 and supplemented with Hoechst (1:2,000) in blocking buffer 
for 2 h. Slides were washed three times for 30 min and mounted with 
Vectashield. All images were first checked by confocal microscopy 
before SIM acquisition.
SIM
For acquiring, processing, and analyzing SIM images on 7W cells and 
mouse brain tissue, a similar protocol to Hong et al. (2015) was fol-
lowed. In brief, all samples were imaged using a microscope (ELY RA 
PS1; Carl Zeiss) with a fixed number of grating rotations (five), and 
images were processed using the accompanying Zen image acquisition 
software (Carl Zeiss). For quantification of mouse hippocampal im-
ages, the processed 3D SIM images were analyzed by Imaris (bitplane) 
and MAT LAB (MathWorks Inc.) using the spot (ellipsoids) function. 
Spots were created at the local maxima of all fluorescent puncta spots, 
and x, y, and z diameters of the ellipsoids were empirically deter-
mined for the particular set of antibodies used and confirmed using 
spot growth boundary so that all spots created appropriately reflected 
the fluorescent image of each channel. Then, MAT LAB was used to 
determine the number of colocalized spots (≤200-nm distance between 
spot centers of two channels). The number of colocated spots was then 
divided by the numbers of spots on the individual channel. All SIM data 
analysis was done blinded.
FLIM
We performed FLIM according to previously described protocols 
(Wahlster et al., 2013; Arimon et al., 2015). In brief, to monitor 
relative proximity between the PS1–γ-secretase and A10–α-secretase 
in intact cells, 7W cells were immunostained with 13A11 and 
AB19026 antibodies against PS1 and A10, respectively. The primary 
antibodies were detected with Alexa Fluor 488 (donor)– and Cy3 
(acceptor)- labeled corresponding secondary antibodies. The Alexa 
Fluor 488 donor fluorophore was excited with a Ti :Sapphire laser 
(Chameleon; Coherent). Images were taken with a microscope (LSM-
510; Carl Zeiss) using a 63× oil immersion objective, and lifetimes 
were recorded using a high-speed photomultiplier tube (MCP R3809; 
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Hamamatsu Photonics) and a fast time-correlated single-photon 
counting acquisition board (SPC-830; Becker & Hickl). All data 
were analyzed using SPC Image software (Becker & Hickl) where 
individual cells were outlined and mean donor fluorophore lifetime 
per cell was quantitated. First, to determine the native lifetime of the 
donor fluorophore (t1; no FRET), a one-component analysis was used 
in the donor fluorophore–only immunostained cells (13A11–Alexa 
Fluor 488). Next, donor- and acceptor-labeled cells were analyzed with 
a two-component analysis, where t1 was fixed (“excluded”) and a new, 
shorter lifetime of the donor fluorophore (t2), because of the presence 
of FRET, was determined. The FRET efficiency (EFR ET) was calculated 
using the following equation: EFR ET = (t1 − t2)/t1 × 100%.
ELI SA
For Aβ, an Aβ1-40 ELI SA (Invitrogen) was performed according to 
the manufacturer’s specifications. Samples were diluted 1:25 to allow 
detection within the standard range. Alternatively, for certain CM 
samples, a meso scale discovery (MSD) Aβ triplex ELI SA was per-
formed with samples diluted 1:5. For APPs, an MSD duplex ELI SA 
that measures APPs-α and APPs-β was performed as described previ-
ously (Hong et al., 2011; Rice et al., 2012) with samples diluted 1:10 
per the manufacturer’s protocol. In brief, plates were blocked with 3% 
blocker A for 60 min followed by incubation with samples and stan-
dards for 60 min. Plates were washed three times before the addition of 
detection antibody for 60 min, followed by another three washes. Read 
buffer was added for 10 min and analyzed on an MSD imager (Sector). 
All incubations (except read buffer) were done with vigorous shaking 
on a titer plate shaker.
Quantification and statistical analysis
All quantifications were performed using an infrared imaging system 
(Odyssey) or using ImageJ software (National Institutes of Health; 
when blots were performed by ECL detection). For APPs-α, Western 
blots using an APPs-α–specific antibody, 1736 or 6E10, were quanti-
tated by LI-COR Biosciences. For APPs-β, an MSD ELI SA was per-
formed with specific standards. In most cases, data were normalized to 
controls that were set to 100%. For statistical analysis, a Student’s t test 
or one-way or two-way analysis of variance (ANO VA) was used when 
appropriate; significance was designated at P < 0.05.
Online supplemental material
Fig. S1 shows additional surface biotinylation and coIP data 
demonstrating cell surface interaction between A10 or TACE with 
γ-secretase. Fig. S2 shows additional imaging data and quantitation 
by confocal and SIM. Fig. S3 characterizes the phenomenon of γ 
inhibition on APPs-α secretion. Fig. S4 demonstrates that modulation 
of γ-secretase by sulindac sulfide or by FAD-causing mutations in 
PS1 does not alter APPs-α secretion. Fig. S5 shows that γ inhibition 
does not increase the coIP between A10 and γ-secretase even though it 
increases APPs-α secretion. Online supplemental material is available 
at http ://www .jcb .org /cgi /content /full /jcb .201502001 /DC1.
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